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Abstract (140 words; max 150) 20 
 21 
Emerging links between circadian rhythms and metabolism promise much for the 22 
understanding of metabolic physiology and pathophysiology, in which white adipose 23 
tissue (WAT) plays a prominent role.  Many WAT endocrine molecules, termed 24 
adipokines, display rhythmic plasma concentration.  Moreover, similar to most other 25 
tissues, WAT exhibits widespread 24-hour variation in gene expression, with 26 
approximately 20% of the murine adipose transcriptome estimated to undergo daily 27 
variation. 28 
 29 
A major limitation to human chronobiology research is the availability of 30 
physiologically defined peripheral tissues.  To date most analyses of in vivo human 31 
peripheral clocks has been limited to blood leukocytes.  However, subcutaneous 32 
adipose tissue represents a novel opportunity to study peripheral molecular rhythms 33 
that are of clearly defined metabolic relevance. 34 
 35 
This review summarises basic concepts of circadian and metabolic physiology before 36 
then comparing alternative protocols used to analyse the rhythmic properties of 37 
human adipose tissue. 38 
 39 
 40 
Keywords (max 6): 41 
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1. Introduction 44 
 45 
One area of circadian biology that is currently receiving great attention is the 46 
interaction between circadian clocks and metabolism.  Evidence linking these two 47 
processes is now widespread and covers multiple disciplines from epidemiology 48 
through to physiology and molecular biology (reviewed in e.g. Asher and Schibler, 49 
2011; Bass and Takahashi, 2010; Garaulet et al., 2010; Froy, 2011).  This review will 50 
initially describe some of the key elements of circadian rhythmicity and its metabolic 51 
interaction, before then focussing on the role of circadian timing within adipose tissue 52 
physiology. 53 
 54 
 55 
2. Circadian clocks: molecular control and links with metabolism 56 
 57 
Circadian clocks are present throughout the living world and regulate a diverse array 58 
of biological processes, including endocrine function (Hastings et al., 2007).  In 59 
mammals, the anatomical framework of circadian rhythms is described by a complex 60 
circadian timing system in which the ‘master’ clock within the suprachiasmatic nuclei 61 
(SCN) of the hypothalamus responds to external photic stimuli and synchronises the 62 
relative phasing of additional clocks found throughout the brain and peripheral tissues 63 
(Dibner et al., 2010). 64 
 65 
Understanding of the molecular basis of circadian timing has proceeded at great pace 66 
over the past fifteen years and detailed reviews of this subject can be found elsewhere 67 
(e.g. Baggs and Hogenesch, 2010; Ukai and Ueda, 2010).  A dominant model of the 68 
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molecular clock is the transcriptional-translational feedback loop (TTFL) model.  At 69 
its heart is a core autoregulatory feedback mechanism in which transcription factors 70 
CLOCK (or its paralogue NPAS2) and BMAL1 stimulate transcription of Period 71 
(Per) and Cryptochrome (Cry) genes.  The translated PER and CRY proteins then 72 
feed back to repress their own transcription.  The importance of these factors is 73 
revealed by the marked disruption of behavioural and molecular rhythms observed in 74 
mice that are homozygous for a dominant negative form of Clock (Clock-19; 75 
Vitaterna et al, 1994), null mutation of the Bmal1 gene (Bunger et al., 2000), or 76 
‘double knockout’ for Per1/Per2 (Bae et al., 2001) or Cry1/Cry2 (van der Horst et al., 77 
1999). 78 
 79 
The simple loop described above is not by itself sufficient to generate a functioning 80 
circadian clock.  Many additional components have now been identified that allow 81 
temporal control of the clock mechanism.  For instance, the casein kinases 1 delta 82 
(CK1δ) and epsilon (CK1ε) provide post-transcriptional control of PER protein 83 
turnover (Lowrey et al., 2000; Akashi et al., 2002; Xu et al., 2005; Meng et al., 2008).  84 
Other key post-translational components within the mammalian TTFL mechanism 85 
include glycogen synthase kinase 3β (GSK3β), which phosphorylates multiple 86 
circadian proteins (Iitaka et al., 2005; Harada et al., 2005; Sahar et al., 2010); the F-87 
box protein FBXL3, which is part of an ubiquitin ligase complex and destabilises 88 
CRY proteins (Busino et al., 2007; Godinho et al., 2007; Siepka et al., 2007); and the 89 
nutrient-responsive enzyme AMP kinase (AMPK), which phosphorylates and 90 
destabilises CRY1 protein (Lamia et al., 2009). 91 
 92 
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Many secondary TTFLs have been identified in which the products of clock-93 
controlled genes are able to feed back into the core loop; these secondary loops are 94 
thought to provide additional stability to the clock mechanism and/or provide 95 
pathways through which intracellular signals can regulate or synchronise clock 96 
function.  Interestingly, a large number of secondary TTFLs include the regulation of 97 
metabolically active genes and proteins.  The best-characterised secondary TTFL 98 
involves the nuclear receptor REV-ERBα (NR1D1), a heme sensor (Raghuram et al., 99 
2007; Yin et al., 2007) that is rhythmically transcribed by CLOCK-BMAL1 100 
complexes and acts to rhythmically repress Bmal1 transcription (Preitner et al, 2002).  101 
Other secondary loops linked to metabolism involve peroxisome proliferator-activated 102 
receptor alpha (PPARα; Canaple et al., 2006), PPARγ co-activator 1α (PGC1α; Liu et 103 
al., 2007) and the nicotinamide adenine dinucleotide (NAD)-dependent histone 104 
deacetylase SIRT1 (Ramsey et al., 2009; Nakahata et al., 2009). 105 
 106 
In addition to the TTFL model, there is a body of evidence indicating that circadian 107 
timing may employ mechanisms that are independent of the cell nucleus.  Early data 108 
supporting such mechanisms included the observation of enzymatic rhythms in 109 
enucleate red blood cells (Mabood et al., 1978).  Subsequent evidence came from the 110 
elegant demonstration of circadian rhythms of phosphorylation of the cyanobacterial 111 
protein KaiC when it is mixed with only two other proteins and ATP in vitro 112 
(Nakajima et al., 2005).  More recently, it has been argued that circadian rhythms in 113 
multiple species are regulated by cytoplasmic signalling systems (reviewed in 114 
Hastings et al., 2008) and that eukaryotic rhythms of peroxiredoxin oxidation can 115 
persist in the absence of transcription and translation (O’Neill and Reddy, 2011; 116 
  
 6 
O’Neill et al., 2011).  A focus of future work in this area is likely to investigate the 117 
functional links between TTFLs and these extra-nuclear circadian mechanisms. 118 
 119 
Strong genetic support for the link between circadian clocks and metabolism has 120 
come from observations that animals with lesions of clock-related genes display 121 
altered metabolic phenotypes.  Examples include Clock-19 mice (Rudic et al., 2004; 122 
Turek et al., 2005; Oishi et al., 2006; Kennaway et al., 2007), and homozygous 123 
‘knockouts’ for Bmal1 (Rudic et al., 2004), Nocturnin (Green et al., 2007), Per1 124 
(Dallmann et al., 2006), Per2 (Yang et al., 2009), Per3 (Dallmann and Weaver, 2010; 125 
Costa et al., 2011), Rev-erbα (Raspe et al., 2002).  Although the specific phenotype 126 
may be partially dependent upon genetic background (discussed in Johnston et al., 127 
2009), the widespread nature of this clock-metabolic interaction is compelling.  128 
Building upon the animal data, numerous studies also report human genetic links 129 
between metabolic status and clock gene polymorphisms of BMAL1 (Woon et al., 130 
2007), CLOCK (Scott et al., 2008; Sookoian et al., 2008; Tsuzaki et al., 2010), NPAS2 131 
and PER2 (Englund et al., 2009). 132 
 133 
Finally, at the level of whole organism physiology, there is a clear relationship 134 
between abnormally timed feeding and metabolic dysfunction.  In human populations, 135 
it is well documented that shift workers exhibit increased obesity and other markers of 136 
cardio-metabolic disease (Biggi et al., 2008; Suwazono et al., 2008; Pietroiusti et al., 137 
2010).  Although shift work includes a strong element of circadian disorder, it is also 138 
characterised by other disturbances, e.g. altered sleep, social interactions, and feeding 139 
quality/behaviour (reviewed in Lowden et al., 2010).  However, human night eating 140 
syndrome is also associated with increased body weight (O’Reardon et al., 2004; 141 
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Colles et al., 2007), suggesting that eating outside the endogenous circadian day may 142 
at least partially explain metabolic disturbances in shift workers.   This view is further 143 
supported by data from a laboratory forced desynchrony protocol (Scheer et al., 2009) 144 
and a wealth of human post-prandial studies demonstrating that nocturnal eating leads 145 
to elevated plasma triacylglycerol, glucose and insulin concentration (reviewed in 146 
Morgan et al, 2003).  In rodent models, caloric intake at abnormal times of day 147 
induces increased body weight gain (Arble et al., 2009) whereas restricting food 148 
intake to the normal activity phase can prevent obesity in simulated ‘night work’ 149 
(Salgado-Delgado et al., 2010).  Furthermore, housing mice on short 20-hour light-150 
dark cycles accelerated body weight gain and caused elevated plasma leptin and 151 
insulin, without any significant change in glucose concentration, consistent with a 152 
reduction of insulin sensitivity (Karatsoreos et al., 2011).  These data suggest that 153 
animal models may be informative in understanding the mechanisms linking timed 154 
feeding behaviour with metabolism. 155 
 156 
 157 
3. Identification and function of adipose rhythms 158 
 159 
Adipose tissue is found in localised depots throughout the body and has multiple 160 
functions.  For many years, it was believed that the roles of white adipose tissue were 161 
restricted to physical cushioning and energy storage.  However, the cloning of the 162 
hormone leptin was pivotal in the identification of fat as an important endocrine tissue 163 
(Zhang et al., 1994).  There are now a large number of identified adipose signalling 164 
molecules, termed adipokines (reviewed in Trujillo and Scherer, 2006; Galic et al., 165 
2010), many of which exhibit 24-hour variation in plasma concentration (Sinha et al., 166 
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1996; Gavrila et al., 2003; Parlee et al., 2010; Scheer et al., 2010).  In rodents, the 167 
diurnal leptin rhythm is dependent upon an intact SCN (Kalsbeek et al., 2001) 168 
demonstrating a functional link with the circadian timing system.  Although these 169 
leptin rhythms could result from numerous factors (e.g. acute response to feeding, 170 
rhythmic clearance), their presence may reflect a circadian component to adipokine 171 
secretion residing locally within adipose tissue.  Indeed, preliminary data from 172 
synchronised murine 3T3-L1 adipocyte cells indicates that one of the functions of the 173 
adipocyte clock may be to regulate leptin secretion (Otway et al., 2009).  Although 174 
this finding needs to be validated using a perfusion culture system, it is nonetheless 175 
consistent with the identification of a circadian component to daily variation in human 176 
plasma leptin data (Shea et al., 2005). 177 
 178 
Molecular evidence for the presence of adipose circadian clocks has come from the 179 
identification of rhythmic clock gene expression in serial murine tissue samples (e.g. 180 
Ando et al, 2005; Zvonic et al., 2006; Kohsaka et al., 2007).  In addition to these 181 
focussed analyses of clock gene expression, array-based approaches have been 182 
applied to adipose tissue in order to estimate the breadth of influence of rhythmical 183 
physiology.  Microarray experiments have provided comprehensive analysis of 24-184 
hour transcriptome regulation in multiple tissues (reviewed in Duffield, 2003), and it 185 
is often regarded that approximately 5-10% of the transcriptome of a given tissue 186 
exhibits daily rhythms. Only a small number of these genes are rhythmic in multiple 187 
tissues, suggesting that most rhythmic genes are tissue-specific outputs of the core 188 
circadian clock.  Analysis of inguinal and epididymal murine adipose tissue has 189 
estimated that up to 20% of the adipose transcriptome undergoes 24-hour variation 190 
(Ptitsyn et al., 2006; Zvonic et al., 2006).  Identification of the rhythmically expressed 191 
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genes strongly suggests that many of the key metabolic functions of adipose tissue are 192 
under temporal control.  However, a caveat in the interpretation of mRNA data comes 193 
from the liver; the hepatic proteome in fact poorly matches its corresponding 194 
transcriptome (Reddy et al., 2006) and thus rhythmicity in the adipose transcriptome 195 
may not accurately reflect protein expression and/or function. 196 
 197 
Tissue-specific disruption of circadian clock function has been successfully 198 
accomplished in transgenic mouse models.  For instance, using this technique, it has 199 
been demonstrated that both the hepatic and pancreatic clocks play key roles in whole 200 
body glucose homeostasis (Lamia et al., 2008; Marcheva et al., 2010; Sadacca et al., 201 
2011).  A similar transgenic approach has used expression of CLOCK-19 driven by 202 
the aP2 promoter to suppress clock function in adipocytes (Bray and Young, 2009).  203 
However, this approach targets not only adipocytes but also other cell types, such as 204 
cardiomyocytes and macrophages.  It is therefore difficult to ascribe a definitive 205 
physiological role to the adipose clock at present.  Recent work has identified a new 206 
adipocyte-specific promoter cassette (Wang et al., 2010) and so it is likely that an 207 
adipocyte-clock knockout mouse will soon be available. 208 
 209 
 210 
4. Molecular analysis of human adipose rhythms 211 
 212 
A major technical limitation that has hindered the study of human circadian rhythms 213 
has been the difficulty in identifying a tissue that can be used to study peripheral clock 214 
function in vivo.  Although visceral adipose depots are not readily accessible, 215 
subcutaneous adipose tissue offer the possibility of sampling that is tolerable for the 216 
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experimental subjects.  Varied experimental approaches have been employed to assess 217 
human adipose rhythms (summarised in Table 1). 218 
 219 
4.1. Single time point analysis 220 
 221 
The simplest way to estimate the association between clock gene expression and 222 
metabolism is to measure the expression of different clock genes at a single time223 
point.  Although this approach may appear counter-intuitive, the relationship between 224 
expression of a given clock gene and either metabolic status or the expression of other 225 
gene(s) may be informative if biopsies are collected at an equivalent time point.  226 
Furthermore, the use of a single biopsy permits the analysis of visceral tissue, which 227 
cannot be repeatedly sampled. 228 
 229 
In one study, BMAL1, PER2 and CRY1 were measured in visceral and subcutaneous 230 
biopsies taken from obese men with BMI  40 (Gómez-Abellán et al., 2008).  The 231 
expression of all three genes in subcutaneous adipose exhibited significant 232 
correlations with plasma concentration of total and low density lipoprotein (LDL) 233 
cholesterol; in visceral adipose PER2 expression was negatively correlated with waist 234 
circumference.  A second study (Wu et al., 2009) compared subcutaneous adipose 235 
mRNA expression with BMI in subjects ranging from lean (BMI < 25) to obese (BMI 236 
> 30).  Expression of most clock genes was found to correlate with that of adipocyte 237 
biomarker genes.  However, correlations between clock gene expression and BMI 238 
were more complex with marked differences found in different subject clusters, 239 
possibly reflecting effects of subject age. 240 
 241 
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Although these experiments provide useful preliminary data linking regional adipose 242 
clock gene expression with metabolic status, they are nonetheless subject to the 243 
disadvantage that a single time point analysis does not permit interpretation of 244 
circadian or diurnal rhythms. 245 
 246 
4.2. Cultured biopsies 247 
 248 
An imaginative method used to circumvent the problems of single time point 249 
sampling has been to culture adipose biopsies taken from human volunteers.  In these 250 
experiments, adipose biopsies have been collected from both subcutaneous and 251 
visceral regions of metabolically characterised subjects.  A single biopsy is split into 252 
pieces which are cultured and then collected for analysis, typically at 6-hourly 253 
intervals over a 24 hour period.  Using this protocol, temporal variation has been 254 
demonstrated for the expression of genes involved in glucocorticoid function, 255 
circadian rhythms and adipokine signalling (Hernández-Morante et al., 2009; Gómez-256 
Santos et al., 2009; Gómez-Abellán et al., 2010).  Cosinor curve fits through the four 257 
time points indicate that there are marked phase differences in mRNA rhythms 258 
between subcutaneous and visceral adipose depots.  This intriguing possibility 259 
suggests that adipose clocks may be depot-specific and thus warrants further 260 
investigation into the coupling and function of adipose clocks. 261 
 262 
In addition to the ability to compare subcutaneous and visceral adipose depots from 263 
the same individuals, this technique permits the identification of endogenous adipose 264 
rhythms.  However the technique does also provide some disadvantages.  Firstly, 265 
temporal resolution of the analysis is limited by the amount of tissue that can be 266 
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surgically removed.  Secondly, by moving the tissue into an in vitro environment, it is 267 
difficult to relate results to in vivo physiology; given the importance of endocrine and 268 
other methods of inter-tissue communication in controlling whole-body metabolism, 269 
the variation between in vivo and in vitro adipose rhythmicity may have important 270 
consequences. 271 
 272 
4.3. Serial biopsies 273 
 274 
Despite tissue sampling restrictions, there has been some progress in the study of 275 
human peripheral rhythms.  To date, the most commonly studied tissue has been 276 
blood leukocyte cells (e.g. Boivin et al., 2003; Fukuya et al., 2007), the rhythms in 277 
which correlate with those of melatonin and cortisol, in addition to sleep-wake timing 278 
(Archer et al., 2008).  More recently, it has been reported that samples of human hair 279 
follicles from head or chin can be used as a marker of human peripheral rhythms 280 
(Akashi et al., 2010).  However, one disadvantage of both leukocyte and hair follicle 281 
rhythms is that they do not have a clear link with metabolic physiology. 282 
 283 
Two studies have now described temporal changes in gene expression using serial 284 
subcutaneous adipose biopsies.  In the first of these studies, three biopsies were 285 
collected over 10.5 hour period; using array analysis of adipose from the umbilical 286 
region of overweight-obese male subjects (BMI range 27-35), they estimated that 287 
approximately 25% of the human adipose transcriptome undergoes diurnal regulation 288 
(Loboda et al., 2009).  Interestingly, there were small but significant differences in 289 
gene signatures in the subjects, dependent upon whether they ate a meal 1-hour after 290 
the first biopsy or not.  In a subsequent study, we have analysed diurnal gene 291 
  
 13 
expression in individuals who are lean, mildly obese or obese with type 2 diabetes 292 
(Otway et al., 2011).  Following a controlled pre-laboratory routine lasting one week, 293 
volunteers were brought into the laboratory for a night of acclimation.  Biopsies were 294 
then collected every 6-hours across a 24-hour period from the upper buttock region, 295 
which is known to contain metabolically active adipose tissue (Khan et al., 2002).  We 296 
observed robust rhythms in all clock genes measured and also in genes that have been 297 
linked to both circadian and metabolic function.  Surprisingly, and in contrast to data 298 
from a similar mouse experiment (Ando et al., 2005), we found no significant 299 
differences in gene expression between our three experimental groups. 300 
 301 
Although these studies are limited to sampling subcutaneous adipose tissue, which is 302 
not as good a predictor of metabolic disease as visceral adipose (Després and 303 
Lemieux, 2006), they nonetheless now validate a protocol for analysis of in vivo 304 
rhythms in a metabolically active tissue.  Furthermore, it is clear that subcutaneous 305 
adipose tissue can be used as a marker of physiologically relevant peripheral clock in 306 
studies of in vivo human chronobiology. 307 
 308 
4.4. Cell culture and real-time analysis of gene expression 309 
 310 
As discussed previously (Johnston et al., 2009; Gimble et al., 2011), one important 311 
consideration when studying adipose tissue is its heterogeneous nature.  Most, if not 312 
all, of the adipose cell types contain their own endogenous clock.  Furthermore, the 313 
relative composition of adipose tissue varies depending upon metabolic state; for 314 
instance, obesity is characterised by increased macrophage infiltration into the tissue.  315 
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A potential limitation of adipose tissue analysis is therefore the uncertainty of which 316 
cell type(s) are contributing towards the observed rhythmicity. 317 
 318 
In addition to work with the murine 3T3-L1 cell line (Otway et al., 2009) described 319 
above, investigators have studied rhythms in human adipocyte cells differentiated 320 
from adipose-derived stem cells (ASCs).  Using a serum pulse technique, such as 321 
pioneered by Balsalobre et al. (1998), followed by analysis of cell lysates collected 322 
every four hours, circadian rhythms of gene expression have been identified in 323 
undifferentiated (Wu et al., 2007; Huang et al., 2009) and adipocyte differentiated 324 
(Wu et al., 2007) ASCs.  Together these data have provided strong support for the 325 
presence of circadian clock within adipocyte cells, the key metabolic cell type within 326 
adipose tissue. 327 
 328 
Published data of adipocyte cell rhythms have thus far been restricted by the sampling 329 
resolution of the methodology described above.  Further understanding of adipocyte 330 
circadian biology will likely require genetic manipulation of the core clockwork 331 
and/or real-time reporter gene analysis to provide superior temporal resolution of 332 
molecular rhythms.  By using lentiviral constructs to transfect primary cells, real-time 333 
reporter imaging has been successfully applied to the study of human skin fibroblasts 334 
in vitro (Brown et al., 2005).  As well as the improved temporal resolution provided 335 
by this approach, it provides the advantage of permitting analysis of multiple 336 
circadian cycles from a small amount of source tissue.  As a result, it may well 337 
therefore be ideal for comparing the circadian properties of multiple adipose depots 338 
taken from both subcutaneous and visceral regions. 339 
 340 
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 341 
5. Conclusions 342 
 343 
The links between circadian and metabolic physiology are becoming clearer and 344 
promise much for the understanding of metabolic disease.  Moreover, the 345 
identification of subcutaneous adipose tissue as an accessible human peripheral clock 346 
will aid the translation of chronobiology to human subjects. 347 
 348 
Although much research into the physiology of circadian metabolism has to date 349 
focussed on the liver and pancreas, there is mounting interest in understanding the 350 
function of adipose and adipocyte clocks.  By using transgenic approaches, a key step 351 
forward will be the analysis of mice bearing a localised ablation of adipose clock 352 
function.  In terms of human physiology, a number of complementary techniques are 353 
now available for experimental use.  However, due to the likely effects of parameters 354 
such as feeding time (Zvonic et al., 2006; Loboda et al., 2009) and subject age (Wu et 355 
al., 2009) on clock gene expression, it will be extremely important for experimental 356 
groups to be tightly controlled in future studies. 357 
 358 
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